We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+25.61%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$2.52B
AUM Growth
+$285M
Cap. Flow
-$147M
Cap. Flow %
-5.84%
Top 10 Hldgs %
84.74%
Holding
33
New
2
Increased
1
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
CVT
CVENT, INC.
CVT
+$266M
2
OREX
Orexigen Therapeutics, Inc.
OREX
+$7.82M
3
TSRO
TESARO, Inc.
TSRO
+$262K

Top Sells

Rank Stock Value
1
GRPN icon
Groupon
GRPN
+$329M
2
OMTH
OMTHERA PHARMACEUTICALS INC COM STK (DE)
OMTH
+$77.7M
3
SMI
Semiconductor Manufacturing Intl
SMI
+$8.3M
4
WIFI
Boingo Wireless, Inc.
WIFI
+$6.76M

Sector Composition

Rank Sector Weight
1 Healthcare 39.89%
2 Communication Services 27.22%
3 Technology 19.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRPN icon
1
Groupon
GRPN
$1.06B
$610M 24.17%
2,720,654
-1,652,000
-38% -$329M
TSRO
2
DELISTED
TESARO, Inc.
TSRO
$382M 15.14%
9,861,412
+7,157
+0.1% +$262K
CVT
3
DELISTED
CVENT, INC.
CVT
$257M 10.17%
+7,299,146
New +$266M
EPZM
4
DELISTED
Epizyme, Inc
EPZM
$242M 9.57%
6,039,589
– –
XOOM
5
DELISTED
XOOM CORP COM
XOOM
$160M 6.36%
5,052,935
– –
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
$139M 5.49%
2,279,781
– –
ECOM
7
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$101M 4.02%
2,767,697
– –
FIO
8
DELISTED
FUSION-IO INC COM
FIO
$94.2M 3.73%
7,038,379
– –
SUPN icon
9
Supernus Pharmaceuticals
SUPN
$2.74B
$78.1M 3.09%
10,650,000
– –
HPTX
10
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$75.4M 2.99%
2,884,221
– –
MM
11
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$58.1M 2.3%
8,224,752
– –
WIFI
12
DELISTED
Boingo Wireless, Inc.
WIFI
$38.3M 1.52%
5,467,960
-973,333
-15% -$6.76M
ADNC
13
DELISTED
AUDIENCE INC COM STK (DE)
ADNC
$32.3M 1.28%
2,878,005
– –
VIRX
14
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$28M 1.11%
26,841
– –
LXRX icon
15
Lexicon Pharmaceuticals
LXRX
$1.03B
$27.8M 1.1%
1,668,000
– –
GYRE icon
16
Gyre Therapeutics
GYRE
$639M
$24.3M 0.96%
5,807
– –
ITMN
17
DELISTED
INTERMUNE INC
ITMN
$20.6M 0.82%
1,341,000
– –
NKTR icon
18
Nektar Therapeutics
NKTR
$2.31B
$19.1M 0.76%
121,707
– –
LNKD
19
DELISTED
LinkedIn Corporation
LNKD
$18.8M 0.75%
76,467
– –
GLUU
20
DELISTED
Glu Mobile Inc.
GLUU
$16.5M 0.65%
5,943,793
– –
DZSI
21
DELISTED
DZS Inc. Common Stock
DZSI
$15.1M 0.6%
956,258
– –
FOLD
22
DELISTED
Amicus Therapeutics
FOLD
$13.1M 0.52%
5,653,029
– –
CADX
23
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
$13M 0.52%
2,070,286
– –
EXEL icon
24
Exelixis
EXEL
$14.1B
$12.8M 0.51%
2,207,000
– –
RIGL icon
25
Rigel Pharmaceuticals
RIGL
$715M
$11.6M 0.46%
324,315
– –
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.76B AUM 13.06% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return

NEA Management Company's Q3 2013 Portfolio in Review

As of Q3 2013, NEA Management Company held 33 positions worth $2.52B, up 13% from $2.24B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

NEA Management Company withdrew a net $147M in Q3 2013, closing 2 positions and reducing 2 holdings. Its most notable exit was OMTHERA PHARMACEUTICALS INC COM STK (DE), an estimated $77.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 39% a quarter earlier, followed by Communication Services and Technology.

Against the trend, NEA Management Company opened a new position in CVENT, INC. worth $257M.

  • NEA Management Company's largest Q3 2013 buy was CVENT, INC.: 7,299,146 shares worth $257M.
  • NEA Management Company added most to TESARO, Inc. in Q3 2013, an estimated $262K increase.
  • NEA Management Company's biggest Q3 2013 reduction was Groupon, cutting an estimated $329M.
  • NEA Management Company fully exited OMTHERA PHARMACEUTICALS INC COM STK (DE) in Q3 2013, selling an estimated $77.7M.
  • NEA Management Company's ten largest holdings make up 85% of its $2.52B portfolio in Q3 2013.
  • NEA Management Company opened 2 new positions and closed 2 in Q3 2013.
  • NEA Management Company's portfolio value rose 13% quarter-over-quarter to $2.52B.

Based on NEA Management Company's 13F filing for Q3 2013, filed 30 Oct 2013.